A retrospective analysis of nonresponse to daily teriparatide treatment

Usefulness of daily teriparatide treatment in elderly patients over 80 years of age

(2016) R. Niimi et al.   OSTEOPOROSIS INTERNATIONAL

Analysis of daily teriparatide treatment for osteoporosis in men

(2015) R. Niimi et al.   OSTEOPOROSIS INTERNATIONAL

Determinants associated with bone mineral density increase in response to daily teriparatide treatment in patients with osteoporosis

(2014) Rui Niimi et al.   BONE

Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients

(2014) K. Ebina et al.   OSTEOPOROSIS INTERNATIONAL

PINP as a biological response marker during teriparatide treatment for osteoporosis

(2014) J. H. Krege et al.   OSTEOPOROSIS INTERNATIONAL

Teriparatide for Idiopathic Osteoporosis in Premenopausal Women: A Pilot Study

(2013) Adi Cohen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy of the dynamic radiographs for diagnosing acute osteoporotic vertebral fractures

(2013) R. Niimi et al.   OSTEOPOROSIS INTERNATIONAL

An algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatide

(2013) R. Niimi et al.   OSTEOPOROSIS INTERNATIONAL

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

(2013) P. Farahmand et al.   OSTEOPOROSIS INTERNATIONAL

Effects of Increasing Age, Dosage, and Duration of PTH Treatment on BMD Increase—A Meta-analysis

(2012) Peter Schwarz et al.   CALCIFIED TISSUE INTERNATIONAL

Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases

(2010) Akimitsu Miyauchi et al.   BONE

PINP as an aid for monitoring patients treated with teriparatide

(2010) Mika Tsujimoto et al.   BONE

Vertebral fracture assessment using a semiquantitative technique

(2010) Harry K. Genant et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Variability in the measured response of bone to teriparatide

(2010) R. P. Heaney et al.   OSTEOPOROSIS INTERNATIONAL

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

(2010) A. Blumsohn et al.   OSTEOPOROSIS INTERNATIONAL

Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: Results from the EUROFORS study

(2009) Jan Borggrefe et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent

(2009) Felicia Cosman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study*

(2008) Helmut Minne et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

(2008) Barbara M Obermayer-Pietsch et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis

(2007) Steven Boonen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis

(2006) Carolyn M. Klotzbuecher et al.   JOURNAL OF BONE AND MINERAL RESEARCH